Sof marja: Radiopharm Theranostics Limited (RADX)

Radiopharm Theranostics (RADX) tovar belgisi

GURU.Markets grafigidagi umumiy sof marjlar universitetlar bilan litsenziyalash shartnomalarining kengayishi bilan bog'liq bo'lib, bunda parametr qiymati -1994.10 ga tengdir. Radiopharm Theranostics (RADX) o'zining samaradorlik o'sishini izotoplar uchun patent himoyasiga asoslaydi, bu esa raqobatchilar uchun to'siqlarni yaratadi. Ushbu ko'rsatkichlarning barqarorligi molekulalarni robotlashtirilgan markirovka qilishni joriy etish orqali ta'minlanadi, bu esa ishlab chiqarishdagi nuqsonlarni minimallashtiradi va laboratoriyalarda xodimlarning radiatsiyaga ta'sirlanishini bartaraf etadi.

radiopharmtheranostics.com (RADX) Sof foyda marjasi: 06.12.2024 - 20.11.2026 davri uchun

RADX (Radiopharm Theranostics Ltd): tahliliy kesimlar va indikatorlar boʻyicha maʼlumotlar

- kompaniyaning birjadagi kapitallashuv ko'rsatkichlari:
Kompaniyaning jamlanma tahliliyoti:Radiopharm Theranostics
Radiopharm Theranostics Limited yetakchi tovari

Ushbu ko'rsatkich ma'lum bir davr mobaynida sof foydaning umumiy daromadga nisbati sifatida hisoblanadi. Mazkur ko'rsatkich daromadni yakuniy moliyaviy natijaga aylantirish samaradorligini belgilaydi. Radiopharm Theranostics (RADX) uchun bu yuqori R&D xarajatlarini hisobga olgan holda, maqsadli radioizotoplar sohasidagi ishlanmalarni monetizatsiya qilish qobiliyatini aks ettiradi. Tarixiy sof marjalarning tahlili biznesning operatsion xarajatlarga chidamliligini baholash imkonini beradi. Ushbu egri chiziq bo'ylab ijobiy dinamika kompaniyaning ilmiy salohiyati kapitalizatsiyasining oshayotganini ko'rsatadi.

Asosiy raqobatchilar

ONC: Sotuvning sof marjinal rentabelligi|Sof marja Halozyme Inc. (HALO)|Sof marja RevMed|Sotuvning sof rentabelligi AAPG (Ascentage Pharma Group)|Sotuvning sof marjinal rentabelligi CGON|UroGen Pharma - Sotuvning sof rentabelligi|Bicara Therapeutics - Sof foyda bo'yicha sotuv rentabelligi|Sotuvning sof marjinal rentabelligi Personalis Inc PSNL|Erasca Oncology - Sotuvning sof marjinal rentabelligi|Sof foyda normasi DCTH (Delcath Corp)|YMAB: Sotuvning sof marjinal rentabelligi|AURA - Kompaniya sotuv marjasi|CADL (Candel Therapeutics Inc.) - Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi ARAY (Accuray)|Sof foyda bo'yicha sotuv rentabelligi SLS (SELLAS Life Sciences Group, Inc.)|ACTU - Sof marja|Sof marja Citius Oncology, Inc. CTOR|HURA - Sof foyda bo'yicha sotuv rentabelligi|protaratx.com - Sotuvning sof marjinal rentabelligi|FATE - Sotuvning sof marjinal rentabelligi|WHWK: Sotuvning sof marjinal rentabelligi|TScan Therapeutics (TCRX) - Sotuvning sof marjinal rentabelligi|Sof marja Champions Oncology|Sof marja XBIT|Sotuvning sof marjinal rentabelligi CVM|Sof foyda bo'yicha sotuv rentabelligi OS Therapies Inc. OSTX|Sotuvning sof marjinal rentabelligi ARTV (Artiva Biotherapeutics)|Sotuvning sof marjinal rentabelligi Adlai Nortye Ltd. ANL|Veru Inc - Sotuvning sof marjinal rentabelligi|Kompaniya sotuv marjasi Tempest Therapeutics TPST|XLO: Sotuvning sof marjinal rentabelligi|Enochian BioSciences (RENB) - Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha sotuv rentabelligi MURA|Kairos Pharma Ltd - Sof foyda marjasi|Sotuvning sof marjinal rentabelligi OKUR|CytoMed Therapeutics Limited (GDTC) - Sof foyda bo'yicha marjinallik|Sotuvning sof marjinal rentabelligi CRIS (Curis, Inc.)|APLM: Sotuvning sof rentabelligi|Tharimmune Corporation - Sotuvning sof marjinal rentabelligi|ADVB: Sof marja|GNPX: Sotuvning sof marjinal rentabelligi|CLDI (Calidi Biotherapeutics Inc.) - Sof marja|Sof marja Sunshine Biopharma, Inc.|Sotuvning sof marjinal rentabelligi xeneticbio.com|Sof marja Salarius (SLRX)|Sof foyda bo'yicha sotuv rentabelligi Purple Biotech PPBT|Sof marja American Oncology Network, Inc. AONC|BeiGene, Ltd. (BGNE) - Sof marja|Checkpoint Therapeutics Inc. - Sotuvning sof marjinal rentabelligi|Sof foyda normasi ELEV (Elevation Oncology)|ICAD (iCAD Corp) - Sof foyda bo'yicha sotuv rentabelligi|Ikena Oncology, Inc. - Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi NTBL|VIRX: Sof foyda normasi|Sof marja MorphoSys Corporation (MOR)|NAYA - Sof marja|Sotuvning sof marjinal rentabelligi AAPGV (Ascentage)